REG - IXICO plc - Director/PDMR Shareholding

IXICOAnnouncement

20/08/2019 17:40

RNS Number : 6952J
IXICO plc
20 August 2019
 


20 August 2019
 
IXICO plc
("IXICO" or the "Company")
 
PDMR share option exercise
IXICO plc (AIM: IXI), the data analytics company delivering insights in neuroscience, announces that on 20 August 2019, John Hall,  SVP Corporate Development, exercised 37,647 share options in the Company resulting in the allotment of new ordinary shares at a price of 30.5p.
 
John Hall is interested in 95,447 Ordinary Shares, representing 0.1 per cent of the enlarged issued share capital of the Company following the placing.
 



1
 


Details of the person discharging managerial responsibilities / person closely associated
 




a)
 


Name
 
 


John Hall
 




2
 


Reason for the notification
 




a)
 


Position/status
 
 


SVP Corporate Development




b)
 


Initial notification /Amendment
 
 


Initial notification




3
 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 




a)
 


Name
 
 


IXICO plc




b)
 


LEI
 
 


2138005M1F59O6HWSA97




4
 


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
 
 




a)
 


Description of the financial instrument, type of instrument


Ordinary Shares in IXICO plc














Identification code


GB00BCLY7L40




 








b)
 


Nature of the transaction
 
 


Exercise of share options




c)
 


Price(s) and volume(s)


 


 


 


 








 


Price(s)


Volume(s)


 








 


30.5p


37,647


 








 


 


 


 




d)
 


Aggregated information


















- Aggregated volume


37,647 shares














- Price


30.5p














e)
 


Date of the transaction
 
 


20/08/19




f)
 


Place of the transaction
 
 


Outside of a trading venue



 



IXICO plc


+44 (0) 20 3763 7498




Giulio Cerroni, Chief Executive Officer
Grant Nash, Chief Financial Officer


















Cenkos Securities PLC (Nominated adviser and sole broker)


+44 (0) 20 7397 8900




Giles Balleny / Max Gould (Corporate Finance)








Michael F Johnson / Russell Kerr (Sales)


















Optimum Strategic Communications


 +44 (0) 203 950 9144




Mary Clark / Anne Marieke Ezendam / Supriya Mathur








ixico@optimumcomms.com







 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHQBLFLKVFXBBZ